Vor Biopharma

VOR NASDAQ IPO2021

about VOR

Vor Biopharma develops biologics and small-molecule therapies targeting rare diseases and oncology.

type open high low market
cap
volume
stock $9.51 $10.21 $9.00 $128.85M 8.56M
eps price to
earnings
price to
sales
operating
margin
profit
margin
yield
-$12.56 n/a n/a 0% 0% 0%